Switching chirality in amino acids


Amino acids are converted to their opposite enantiomers by complexation with a nickel(II) salt and a chiral ligand

An international team of scientists has developed a purely chemical approach to interconvert L- and D-amino acids. This method could rival enzymatic routes used in industry, and enable cheaper production of some pharmaceuticals.

While L-amino acids are an inexpensive and renewable source of chiral molecules, used by all cells to synthesise proteins, D-amino acids are scarce in nature and consequently more expensive. Despite their rarity in biological systems, D-amino acids are widely used in the pharmaceutical industry, occurring in many drugs, including antibiotics such as penicillin and anticancer agents such as goserelin.

Currently, D-amino acids are prepared industrially by enzymatically resolving racemic mixtures of amino acids. A readily available source of D-amino acids would obviate the need for resolution, simplifying synthetic routes to many pharmaceuticals.

Vadim Soloshonok, Ikerbasque Research Professor at the University of the Basque Country, Spain, and his colleagues, used inexpensive nickel(II) acetate and a modularly designed chiral ligand derived from α-(phenyl)ethylamine to transform natural amino acids into their unnatural enantiomers. A Ni(II) amino acid Schiff base complex with three stereogenic centres, including a stereogenic nitrogen, was formed under mild and operationally simple reaction conditions. The complex enables the stereocontrolled deprotonation of the α-carbon of amino acids to invert their stereochemistry.

Soloshonok says that this methodology could have a potentially huge impact on the multi-billion dollar amino acid market. ‘D-amino acids are starting materials in the synthesis of pharmaceutical drugs and if we can reduce the price of the starting materials we can make the pharmaceuticals more affordable to people.’

Dominic Campopiano, an expert in enzymology at the University of Edinburgh, UK, describes the new process as ‘neat and clever’ and an improvement over earlier methods. However, he notes that the reaction will be more difficult with bulkier and branched chain amino acids.

Soloshonok acknowledges that there are still many aspects to improve in their methodology. He is now working to extend the scope of the reaction to include functionalised amino acids.


Related Content

The origin of homochirality

26 October 2015 Premium contentFeature

news image

Why do so many biological molecules exist in just one chirality – and how did it emerge? Rachel Brazil reflects on life’s...

Redesigning nature's catalysts

30 June 2011 Premium contentFeature

news image

Harnessing the power of enzymes to perform reactions outside their normal abilities is adding powerful tools to the synthetic...

Most Commented

Countries ink Paris climate change agreement

27 April 2016 News and Analysis

news image

Nearly 200 countries signed the global climate treaty that aims to limit temperature rises to ‘well below’ 2°C

Shadow of Chernobyl

26 April 2016 Critical Point

news image

Mark Peplow takes the long view on the cost of nuclear power